56.02 USD
▲-0.91+1.89%
盘后 54.85 -0.24%
2026-08-03
市值
$5.21B
市盈率
—
EPS
-0.24
股息率
—
52 周区间
15.42 – 60.10
成交量
2.46M
Beta
1.11
目标价
59.14
52W 低 15.4252W 高 60.10
价格走势
公司简介
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company’s products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urin...